Aug 2026
Naringenin alleviates age-related bone loss by targeting Runx2.
BACKGROUND AND PURPOSE Senile osteoporosis presents a significant and growing health burden. Currently, no pharmacological agents are specifically approved for this condition. The dietary flavonoid naringenin (NAR) exhibits osteoprotective potential; however, its efficacy and direct molecular target in the context of s...
Chuanxin Sun, Yuke He, Fu Xiao et al.
· British Journal of Pharmacol... · 0 citations